Acromegaly Treatment Market, By Product Type (Growth Hormone Receptor Antagonists, Somatostatin Analogs, Dopamine Agonists and Others), By Route of Administration, By Distribution Channel, By Treatment Type, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV5938
|
Published Date
September 2026
|
Pages
303
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Acromegaly Treatment Market size was valued at US$ 1,807.6 Million in 2025, expanding at a CAGR of 6.5% from 2026 to 2033.
The acromegaly treatment market comprises a wide range of drug therapies and therapy monitoring that aids biochemical control when surgery may not be appropriate, unsuccessful, or ineffective. The key products used in its treatment are somatostatin analogs, growth hormone receptor antagonists, dopamine agonists, and newer endocrine therapies. The choice of treatment is now more firmly directed by parameters such as the rate of response in terms of IGF-1, tumor characteristics, tolerability, complexity, burden of dosing, and past treatment experience. In 2025, therapeutic choices remain broad class-wise, while oral delivery has increased market significance after the FDA approval of paltusotine for use in the USA. Somatostatin analogs, dopamine agonists, and pegvisomant are a few of those recorded by the FDA as therapies. Therefore, market share is no longer about offering treatments but about effectiveness, convenience, and individuality.
Acromegaly Treatment Market- Market Dynamics
Oral Administration Is Reshaping Treatment Convenience and Product Competition
A strong near-term driver is the trend toward less burdensome administration via an oral formulation. In September 2025, the FDA approved paltusotine, the first once-daily oral therapy for the treatment of acromegaly in adult patients. The FDA approval was based on two pivotal phase III trials, which enrolled 169 patients across 73 centers in 18 countries, demonstrating the drug\'s efficacy: biochemical control at week 24 was achieved in 56% of treated patients in one trial and 83% in another, compared to 5% and 4% with placebo, respectively. As a result, the commercial success of convenient once-daily dosing gained significant momentum, creating a challenge for other injectable agents on the market. In this context ease of administration is a relevant and evolving competitive factor.
Acromegaly Treatment Market- Segmentation Analysis:
The Global Acromegaly Treatment Market is segmented on the basis of Product Type, Route of Administration, Distribution Channel, Treatment Type, and Region.
By product type, the growth hormone receptor antagonists are mainly indicated in cases where biochemical control is not achieved by using other forms of medication, with pegvisomant causing a decrease in IGF-1 by inhibiting the growth hormone receptor. Somatostatin receptor agonists form the main category of pharmacotherapy due to their ability to inhibit growth hormone secretion, while the use of dopamine agonists is usually more targeted, given that they are less effective in many individuals. Paltusotine, an oral form of the somatostatin receptor agonist branded Palsonify, came onto the market in 2025 after being approved by the FDA. This approval provided a once-daily oral form of medication for adults with acromegaly who do not respond to surgery or for whom surgery is not an option.
By Route of Administration, medical laboratory testing is the primary segment for diagnosing acromegaly, where IGF-1 levels are assessed for screening purposes, while growth hormone suppression tests confirm the diagnosis. Similarly, medical imaging is a critical component of evaluation, where MRI is typically used to visualize the pituitary gland and determine the tumor\'s size and location. Both laboratory tests and imaging are used complementarily, with the former evaluating hormone levels and establishing the diagnosis, while the latter determines the tumor\'s characteristics. In 2025, FDA trials for paltusotine used IGF-1 levels as the main indicator of biochemical response to treatment. Therefore, medical testing is the cornerstone of evaluating acromegaly, which guides clinicians in the selection of pharmacological interventions.
Acromegaly Treatment Market- Geographical Insights
North America remains leading market due to the presence of well-established endocrine therapeutics, regulatory activity, specialized care, and commercialization of innovative modes of therapy. In particular, in September 2025, the FDA approved paltusotine after two pivotal phase III trials were completed across 73 centers and 169 patients in 18 countries. This led to the first FDA-approved once-daily oral therapy for acromegaly. According to Crinetics, the company\'s sales force contacted more than 95% of key payers and target physicians during the product launch period. This specialty-centric approach helped the company achieve a significant foothold in the market. North America is, therefore, an important base for innovative and convenient modes of therapy.
Europe is an important market due to the presence of well-established treatment centers, a network of specialist physicians, and access to established long-acting somatostatin analogs. According to Ipsen, Somatuline Autogel/Depot was available in nearly 70 different countries worldwide at the end of 2025. The company also reported that 52.1% of the 2025 Somatuline sales were made in North America, thus highlighting the role of Europe as part of a global supply and sales network, rather than a stand-alone regional market. As such, the European market is mainly influenced by the availability of treatment specialties, the use of existing injectable therapies, and the shift towards more convenient approaches.
Acromegaly Treatment Market- Competitive Landscape:
Market competition in the treatment of acromegaly now revolves around mechanisms of action, biochemical control, administration frequency, tolerability, and administration convenience. Long-acting somatostatin receptor agonists will continue to play an important role due to the mechanism involved in biochemical disease control, whereas pegvisomant represents an alternative method of disease management through a growth hormone receptor antagonist. Oral medication administration has gained increasing importance with the FDA approval of Palsonify (paltusotine) in September 2025, an orally administered somatostatin receptor agonist taken on a daily basis. The new option introduces greater administration convenience compared with injectable therapies and may intensify competition regarding adherence, patient preference, treatment switching, and long-term disease management.
Recent Developments:
- In September 2025, Crinetics Pharmaceuticals received FDA approval for Palsonify (paltusotine) for the treatment of acromegaly in adults who are unsuitable for surgery or have had an inadequate response to surgery. The new therapy was the first once-daily oral treatment for acromegaly in the United States, differentiating itself through the convenience of administration.
- In November 2025, Crinetics announced that Palsonify had been launched in the U.S., with the company\'s field force having engaged with over 95% of key care providers. Early market feedback suggested that the product was being adopted by both switchers and new users, providing commercial validation for the oral formulation
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ACROMEGALY TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- Ipsen Biopharmaceuticals, Inc.
- Pfizer Inc.
- Recordati S.p.A.
- Chiesi Farmaceutici S.p.A.
- Crinetics Pharmaceuticals, Inc.
- Camurus AB
- Ionis Pharmaceuticals, Inc.
- Sun Pharmaceutical Industries Ltd.
- Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Wockhardt Ltd.
- Dauntless Pharmaceuticals
- GlaxoSmithKline plc
- Cipla Ltd.
- Others
GLOBALACROMEGALY TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Growth Hormone Receptor Antagonists
- Somatostatin Analogs
- Dopamine Agonists
- Others
GLOBAL ACROMEGALY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033
- Injectable
- Oral
GLOBAL ACROMEGALY TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
GLOBAL ACROMEGALY TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2020 - 2033
- Drug Therapy
- Surgery
- Radiation Therapy
GLOBAL ACROMEGALY TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. Acromegaly Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Acromegaly Treatment Market Snippet by Product Type
2.1.2. Acromegaly Treatment Market Snippet by Route of Administration
2.1.3. Acromegaly Treatment Market Snippet by Distribution Channel
2.1.4. Acromegaly Treatment Market Snippet by Treatment Type
2.1.5. Acromegaly Treatment Market Snippet by Country
2.1.6. Acromegaly Treatment Market Snippet by Region
2.2. Competitive Insights
3. Acromegaly Treatment Key Market Trends
3.1. Acromegaly Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Acromegaly Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Acromegaly Treatment Market Opportunities
3.4. Acromegaly Treatment Market Future Trends
4. Acromegaly Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Acromegaly Treatment Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Acromegaly Treatment Market Landscape
6.1. Acromegaly Treatment Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Acromegaly Treatment Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Growth Hormone Receptor Antagonists
7.1.3. Somatostatin Analogs
7.1.4. Dopamine Agonists
7.1.5. Others
8. Acromegaly Treatment Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
8.1.2. Injectable
8.1.3. Oral
9. Acromegaly Treatment Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
9.1.2. Retail Pharmacies
9.1.3. Hospital Pharmacies
9.1.4. Online Pharmacies
10. Acromegaly Treatment Market – By Treatment Type
10.1. Overview
10.1.1. Segment Share Analysis, By Treatment Type, 2025 & 2033 (%)
10.1.2. Drug Therapy
10.1.3. Surgery
10.1.4. Radiation Therapy
11. Acromegaly Treatment Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Acromegaly Treatment Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Acromegaly Treatment Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Acromegaly Treatment Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Acromegaly Treatment Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Acromegaly Treatment Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Acromegaly Treatment Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Novartis AG
12.2.2. Ipsen Biopharmaceuticals, Inc.
12.2.3. Pfizer Inc.
12.2.4. Recordati S.p.A.
12.2.5. Chiesi Farmaceutici S.p.A.
12.2.6. Crinetics Pharmaceuticals, Inc.
12.2.7. Camurus AB
12.2.8. Ionis Pharmaceuticals, Inc.
12.2.9. Sun Pharmaceutical Industries Ltd.
12.2.10. F. Hoffmann-La Roche Ltd.
12.2.11. Merck & Co., Inc.
12.2.12. Wockhardt Ltd.
12.2.13. Dauntless Pharmaceuticals
12.2.14. GlaxoSmithKline plc
12.2.15. Cipla Ltd.
12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ACROMEGALY TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- Ipsen Biopharmaceuticals, Inc.
- Pfizer Inc.
- Recordati S.p.A.
- Chiesi Farmaceutici S.p.A.
- Crinetics Pharmaceuticals, Inc.
- Camurus AB
- Ionis Pharmaceuticals, Inc.
- Sun Pharmaceutical Industries Ltd.
- Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Wockhardt Ltd.
- Dauntless Pharmaceuticals
- GlaxoSmithKline plc
- Cipla Ltd.
- Others
GLOBALACROMEGALY TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Growth Hormone Receptor Antagonists
- Somatostatin Analogs
- Dopamine Agonists
- Others
GLOBAL ACROMEGALY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033
- Injectable
- Oral
GLOBAL ACROMEGALY TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
GLOBAL ACROMEGALY TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2020 - 2033
- Drug Therapy
- Surgery
- Radiation Therapy
GLOBAL ACROMEGALY TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
